The health secretary has made many inaccurate statements about vaccines. But the science is clear that vaccines have ...

TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very ...

The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health ...

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, ...

Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising ...

Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly ...

The rate of COVID-related intensive care unit (ICU) admissions was 9.2 per 1,000 person-years among patients who received a ...

Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.